The Effects of Methylphenidate on Ventricular Repolarization Parameters in Children with Attention-Deficit Hyperactivity Disorder

被引:4
|
作者
Tanir, Yasar [1 ]
Erbay, Muhammed Furkan [1 ]
Ozkan, Selcuk [2 ]
Ozdemir, Rahmi [3 ]
Orengul, Abdurrahman Cahid [1 ]
机构
[1] Istanbul Univ, Istanbul Med Fac, Dept Child & Adolescent Psychiat, Istanbul, Turkiye
[2] Kutahya Hlth Sci Univ, Evliya Celebi Training & Res Hosp, Dept Child & Adolescent Psychiat, Kutahya, Turkiye
[3] Kutahya Hlth Sci Univ, Evliya Celebi Training & Res Hosp, Dept Pediat Cardiol, Kutahya, Turkiye
来源
ALPHA PSYCHIATRY | 2023年 / 24卷 / 05期
关键词
Attention-deficit hyperactivity disorder; cardiovascular effects; electrocardiog-raphy; methylphenidate; children; T-END INTERVAL; DEFICIT/HYPERACTIVITY DISORDER; RELEASE METHYLPHENIDATE; RISK; RISPERIDONE; ADHD; PEAK; ADOLESCENTS; DISPERSION; THERAPY;
D O I
10.5152/alphapsychiatry.2023.231185
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Long-acting methylphenidate (MPH), a psychostimulant agent, is widely used in the treatment of attention-deficit hyperactivity disorder (ADHD). Methylphenidate might cause an increment in the risk of lethal arrhythmias by deteriorating ventricular repolarization. QT intervals, the corrected QT (QTc), QT dispersion, T-peak to T-end (TpTe), and the TpTe/QTc ratio are the most utilized indicators of ventricular repolarization in electrocardiogram (ECG). The present study was conducted to examine the effects of long-term MPH use on the ECG in pediatric patients.Methods: A total of 52 children with ADHD and 51 age- and gender-matched controls were enrolled in the study. The children had been using MPH regularly for at least 6 months. Comparisons were made regarding ECG parameters, including the mean intervals of QT, QTc, QTc dispersion interval duration, TpTe intervals, TpTe/QT, and TpTe/QTc ratio.Results: The median duration of treatment with MPH was 30 months (minimum-maximum: 6-120), and the median MPH dose was 30 mg/day (minimum-maximum: 18-54). The main findings showed significantly prolonged P-wave dispersion, TpTe interval, TpTe dispersion, and TpTe/QT and TpTe/QTc ratios in the ADHD group compared to the healthy controls (P < .001). These parameters were not associated with MPH dose or treatment duration. Additionally, nearly half of the patients had QTc values of 460 ms or higher, but there were no significant differences in treatment duration and dose compared to the remaining group (P = .792 and P = .126).Conclusion: Methylphenidate may have proarrhythmogenic effects in children with ADHD, which may not be adversely affected by long-term use and treatment dose. Considering the extensive use of MPH, cardiac monitoring of these children is important.
引用
收藏
页数:66
相关论文
共 50 条
  • [31] Mediators of Methylphenidate Effects on Math Performance in Children with Attention-Deficit Hyperactivity Disorder
    Froehlich, Tanya E.
    Antonini, Tanya N.
    Brinkman, William B.
    Langberg, Joshua M.
    Simon, John O.
    Adams, Ryan
    Fredstrom, Bridget
    Narad, Megan E.
    Kingery, Kathleen M.
    Altaye, Mekibib
    Matheson, Heather
    Tamm, Leanne
    Epstein, Jeffery N.
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2014, 35 (02): : 100 - 107
  • [32] Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder
    Safavi, Parvin
    Dehkordi, Ali Hasanpour
    Ghasemi, Nasim
    JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, 2016, 7 (04) : 144 - 148
  • [33] Use of methylphenidate in attention-deficit hyperactivity disorder
    Jean-Tron, Maria G.
    Marquez-Gonzalez, Horacio
    Barragan-Perez, Eduardo
    Barajas-Nava, Leticia A.
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2020, 77 (01): : 42 - 45
  • [36] Methylphenidate for Attention-Deficit/Hyperactivity Disorder Reply
    Storebo, Ole Jakob
    Simonsen, Erik
    Gluud, Christian
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (09): : 995 - 995
  • [37] HEMISPHERIC PROCESSING AND METHYLPHENIDATE EFFECTS IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    MALONE, MA
    KERSHNER, JR
    SWANSON, JM
    JOURNAL OF CHILD NEUROLOGY, 1994, 9 (02) : 181 - 189
  • [38] Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder
    Danielle C. Turner
    Andrew D. Blackwell
    Jonathan H. Dowson
    Andrew McLean
    Barbara J. Sahakian
    Psychopharmacology, 2005, 178 : 286 - 295
  • [39] Methylphenidate in adults with attention-deficit/hyperactivity disorder
    Koesters, M.
    Weinmann, S.
    Becker, T.
    NERVENARZT, 2007, 78 (09): : 1065 - 1066
  • [40] Effects of methylphenidate on EEG coherence in attention-deficit/hyperactivity disorder
    Clarke, AR
    Barry, RJ
    McCarthy, R
    Selikowitz, M
    Stuart, J
    Johnstone, SJ
    Croft, SJ
    AUSTRALIAN JOURNAL OF PSYCHOLOGY, 2004, 56 : 40 - 40